Literature DB >> 17028920

Diagnostic identification of malignant cells in the cerebrospinal fluid by tumor-specific qRT-PCR.

Cristina Rosanda1, Claudio Gambini, Barbara Carlini, Massimo Conte, Bruno De Bernardi, Alberto Garaventa, Maria Valeria Corrias.   

Abstract

Tumor specific quantitative RT-PCRs for two neuroblastoma specific molecular markers, tyrosine hydroxylase (TH) and GD2 synthase, were used to unequivocally demonstrate the neoplastic nature of the cells present in the cerebrospinal fluid of a neuroblastoma patient. After radical surgery of two separate tumoral lesions, localized in the extradural area, the patient presented with meningitis. Common sites of neuroblastoma metastatization, e.g. bone and bone marrow, were not infiltrated by tumor cells, as assessed by standard scintigraphy, morphological investigation and by sensitive and specific immunocytochemical and molecular assays. The results presented here demonstrate the successful use of tumor-specific qRT-PCRs in cerebrospinal fluid to investigate questionable clinical cases. The technique, which compared to other detection methods (e.g., immunocytochemistry) requires very few cells, yields unambiguous information once a suspected diagnosis has been formulated and a tumor-specific molecular marker is available.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028920     DOI: 10.1007/s10585-006-9032-z

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  19 in total

Review 1.  Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.

Authors:  K Kramer; B Kushner; G Heller; N K Cheung
Journal:  Cancer       Date:  2001-04-15       Impact factor: 6.860

Review 2.  Neuroblastoma: current drug therapy recommendations as part of the total treatment approach.

Authors:  F Berthold; B Hero
Journal:  Drugs       Date:  2000-06       Impact factor: 9.546

Review 3.  Neuroblastoma: biological insights into a clinical enigma.

Authors:  Garrett M Brodeur
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

4.  Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.

Authors:  Katherine K Matthay; Hervé Brisse; Dominique Couanet; Jerome Couturier; Jean Bénard; Veronique Mosseri; Véronique Edeline; Jean Lumbroso; Dominique Valteau-Couanet; Jean Michon
Journal:  Cancer       Date:  2003-07-01       Impact factor: 6.860

Review 5.  Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Authors:  G M Brodeur; J Pritchard; F Berthold; N L Carlsen; V Castel; R P Castelberry; B De Bernardi; A E Evans; M Favrot; F Hedborg
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

Review 6.  A systematic review of molecular and biological tumor markers in neuroblastoma.

Authors:  Richard D Riley; David Heney; David R Jones; Alex J Sutton; Paul C Lambert; Keith R Abrams; Bridget Young; Alan J Wailoo; Susan A Burchill
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

7.  Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.

Authors:  Michel Peuchmaur; Emanuele S G d'Amore; Vijay V Joshi; Jun-ichi Hata; Borghild Roald; Louis P Dehner; Robert B Gerbing; Daniel O Stram; John N Lukens; Katherine K Matthay; Hiroyuki Shimada
Journal:  Cancer       Date:  2003-11-15       Impact factor: 6.860

8.  Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma.

Authors:  B De Bernardi; C Pianca; L Boni; M Brisigotti; M Carli; S Bagnulo; P Corciulo; A Mancini; C De Laurentis; M T Di Tullio
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

Review 9.  Neuroblastoma: biology and molecular and chromosomal pathology.

Authors:  Manfred Schwab; Frank Westermann; Barbara Hero; Frank Berthold
Journal:  Lancet Oncol       Date:  2003-08       Impact factor: 41.316

10.  Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow.

Authors:  Katrien Swerts; Peter F Ambros; Chantal Brouzes; José M Fernandez Navarro; Nicole Gross; Dyanne Rampling; Roswitha Schumacher-Kuckelkorn; Angela R Sementa; Ruth Ladenstein; Klaus Beiske
Journal:  J Histochem Cytochem       Date:  2005-06-13       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.